batirtze-areitio Batirtze Areitio Batirtze has over 5 years of experience in the biopharma and biotech industries. She joined ApexOnco in 2025 after working as an analyst at OncologyPipeline. She is a graduate of the University of Navarra, where she earned a degree in biochemistry. Novocure gets a new field 12 February 2026 Zanzalintinib's second-wave push 11 February 2026 Latest Keytruda Qlex nod shows ongoing complexity 11 February 2026 Lilly’s cautious entry into in vivo Car-T 9 February 2026 Eisai becomes a checkpoint player 6 February 2026 Lilly misses its Point 5 February 2026 GSK moves fast in GIST 4 February 2026 A glimmer of hope for bemarituzumab? 4 February 2026 Load More